The Cartagena Protocol on Biosafety that was adopted by governments on 29 January 2000 is the main international legally binding treaty that regulates ?the safe transfer, handling and use of living modified organisms resulting from modern biotechnology? that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health?.

It is significant as the first global treaty to attempt to contribute to the protection of biodiversity and human health in this field, and as the first treaty to operationalise the precautionary approach in decision-making relating to imports under the Protocol. As of 22 February 2005, there are 113 Parties to the Protocol.

Although the Protocol focuses on transboundary movements of GMOs, its provisions do influence national and regional biosafety policies and laws, bearing in mind that the Protocol sets minimum requirements and Parties have the right to formulate more comprehensive national laws with higher standards. This is reaffirmed in Article 2(4).

Meanwhile, work and standard setting are also taking place in other international fora, such as the Codex Alimentarius, the International Plant Protection Convention and the International Office of Epizootics, the UN Food and Agriculture Organisation and the World Health Organisation.

The linkages among trade, environment and health means that developments at the World Trade Organisation also impact on biosafety and vice versa.

A field of growing importance is the development of biological weapons as part of biodefence programmes where the adequacy of global rules and standards needs examinination.

ISP to FAO: GM Crops Not the Answer

The Independent Science Panel took the FAO to task for the latter’s position on genetic engineering. […]

The Cartagena Biosafety Protocol and the WTO agreements

The relationship between the Cartagena Protocol on Biosafety and the WTO agreements has yet to be settled. The following article examines how the WTO agreements impact on biosafety and the Cartagena Protocol. […]

The Cartagena Biosafety Protocol and the WTO agreements (Chinese)

The relationship between the Cartagena Protocol on Biosafety and the WTO agreements has yet to be settled. The following article examines how the WTO agreements impact on biosafety and the Cartagena Protocol. […]

Submission to the WTO by academics

Submission of an amicus curiae to the WTO by a group of academics in relation to the case of “EC: Measures Affecting the Approval and Marketing of Biotech Products”. […]

Submission to the WTO by the Amicus Coalition

Submission of an amicus curiae by a group of NGOs to the WTO in relations to the case of “EC: Measures Affecting the Approval and Marketing of Biotech Products”. […]

Biosafety Protocol takes bold moves

International regulation of the trade in GMOs took a vital step forward when governments adopted several measures at the first Meeting of the Parties to the Cartagena Protocol on Biosafety held in Kuala Lumpur, Malaysia in Feb 2004. […]

Biosafety Protocol takes bold moves (Chinese)

International regulation of the trade in GMOs took a vital step forward when governments adopted several measures at the first Meeting of the Parties to the Cartagena Protocol on Biosafety held in Kuala Lumpur, Malaysia in Feb 2004. […]

The Cartagena Biosafety Protocol is just the beginning (Chinese)

The article outlines the progress made thus far by the Cartagena Protocol on Biosafety and examines the challenges ahead. […]

The Cartagena Biosafety Protocol is just the beginning

The article outlines the progress made thus far by the Cartagena Protocol on Biosafety and examines the challenges ahead. […]

Some key issues for MOP1

Lim Li Lin considers some of the vital issues to be taken up at the first Meeting of the Parties to the Cartagena Protocol on Biosafety in February 2004 in Kuala Lumpur. […]